Home » Monitoring & Diagnostics » Microneedle Diagnostics

Microneedle Diagnostics


microneedle diagnostics   Published May 2016  •  Catalog no. MDG592F  •  Price US $3,850



Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to incorporate companion diagnostics into their practice areas. Microneedle technology has the potential to address the growing trend toward point of care diagnostics and ambulatory patient monitoring by allowing the precise detection of biomarkers and analytes in fluids and tissues located below the skin. To succeed, developers must refine the techniques available and in development for sampling very small quantities and/or concentrations of analytes and biomarkers, and advance the design integration of microneedles into commercially viable diagnostic platform.

Bar_Graph  Microneedle Diagnostics Report Brochure (Download PDF)

Blue document   Microneedle Diagnostics Report Order Form (Download PDF)


What You Will Learn

• What companies are active in the microneedle diagnostics segments, what distinguishes their technology, and what is their market presence?

• Who are the microneedle diagnostic device developers/suppliers, and what are their capabilities?

• What are the major factors that are influencing demand for microneedle diagnostics?

• What are the essential design factors, material selection issues, technologies and market development issues for diagnostic microneedle products?

• What are the important healthcare markets for microneedle diagnostics? What is their market potential? What will it be in 2020?

• What are the significant economic, technology, and regulatory factors affecting the market for diagnostic microneedles?


Microneedle Diagnostics  – Summary of Contents

Executive Summary

The Market Opportunity

Microneedle Diagnostics Market Dynamics
The Economics of Microneedle Diagnostics
What’s Driving the Growth in microneedle Diagnostics?
Shifting Patient Demographics
Innovation in Microneedle Fabrication
Disease and Condition Demand Drivers
Competitive Landscape
Risk Factors

Microneedle Diagnostics – Design Factors

Materials Selection
Sensor – Array Integration
Microneedle Fabrication
Surface Modification

Diagnostic Microneedle Device Analysis

Interstitial Fluid Sampling
Epidermal Sampling
Spectroscopy-enabled Sampling
Hematology Sampling
Electrode-enabled Detection

Microneedle Diagnostics – Key Therapeutic Sectors

Analyte Sampling
Blood Sample Collection
Diabetes
Glucose
Immune Factors
Infectious Disease
Metabolic Conditions
Oncology
Orthopedics

Government and Academic Programs

Market Factors

Regulatory Issues
Device Branding
Patient Compliance and Ease of Use
Healthcare Economics

Company Profiles